Dr. DEBLINA SARKAR

Employment

• Tata Translational Cancer Research Center, Tata Medical Center Research Scientist II (NM)
  2025 - Present
• IPGME&R, Kolkata Senior Research Scholar
  2020 - 2025
• IPGME&R, Kolkata Junior Research Scholar
  2017 - 2020

Education

• University of Calcutta Ph.D.
  2020 - 2025
• University of Calcutta M.Sc
  2014 - 2016

Projects & Funding

Projects & funding information is unavailable.

Publications (12)

• Post-kala-azar dermal leishmaniasis: a global overview
  Clinical and Experimental Dermatology 2026 DOI: 10.1093/ced/llag010
  +Save
• Sterol Endoperoxides and Their Antileishmanial Effects: Influence on Viability, Oxygen Metabolism and Sterol Synthesis
  Molecules 2026 DOI: 10.3390/molecules31060979
  +Save
• Targeting mitochondrial bioenergetics: the “Achilles’ heel” of Leishmania
  Parasites & Vectors 2026 DOI: 10.1186/s13071-026-07247-x
  +Save
• Evaluating the leishmanicidal activity of m-Nitrocinnamic acid containing lipophilic peptide against leishmania donovani
  Acta Tropica 2025 DOI: 10.1016/j.actatropica.2025.107703
  +Save
• Natural endoperoxides as promising anti-leishmanials
  Phytomedicine 2024 DOI: 10.1016/j.phymed.2024.155640
  +Save
• Flow Cytometric Monitoring of the Redox Status in Health and Disease
  Flow Cytometry 2024 DOI: 10.1007/978-981-97-4553-1_13
  +Save
• Evaluation of Recombinase Polymerase Amplification assay for monitoring parasite load in patients with kala-azar and post kala-azar dermal leishmaniasis
  PLOS Neglected Tropical Diseases 2023 DOI: 10.1371/journal.pntd.0011231
  +Save
• Ascaridole exerts the leishmanicidal activity by inhibiting parasite glycolysis
  Phytomedicine 2022 DOI: 10.1016/j.phymed.2022.154221
  +Save
• Quantitative monitoring of experimental and human leishmaniasis employing amastigote-specific genes
  Parasitology 2022 DOI: 10.1017/s0031182022000610
  +Save
• First‐in‐class pyrido[2,3‐d]pyrimidine‐2,4(1H,3H)‐diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights
  Archiv der Pharmazie 2022 DOI: 10.1002/ardp.202100440
  +Save